JCE:既往存在胺碘酮相关甲亢的房颤患者导管消融后复发率较高
2013-05-02 JCE 丁香园
环肺静脉消融术是心房颤动的有效治疗手段,近年来随着消融技术的进展,越来越多的患者通过导管消融术根治了房颤,然而williamhill asia 也认识到导管消融治疗房颤存在较高的复发率,因此寻找房颤复发的预测因素具有重要意义,既往多项临床研究表明左心房大小、高血压、高血糖及房颤的持续时间是房颤复发的预测因素,也有部分临床表明房颤后新发房性心动过速、持续性房颤、大面积的环肺静脉消融和左心房线状消融可预测房颤复发。目前认为存在并发
环肺静脉消融术是心房颤动的有效治疗手段,近年来随着消融技术的进展,越来越多的患者通过导管消融术根治了房颤,然而williamhill asia
也认识到导管消融治疗房颤存在较高的复发率,因此寻找房颤复发的预测因素具有重要意义,既往多项临床研究表明左心房大小、高血压、高血糖及房颤的持续时间是房颤复发的预测因素,也有部分临床表明房颤后新发房性心动过速、持续性房颤、大面积的环肺静脉消融和左心房线状消融可预测房颤复发。
目前认为存在并发疾病可能影响房颤消融的成功率,甲状腺功能亢进是房颤患者常见的合并症,尤其是长期服用胺碘酮者。然而甲亢是否影响房颤消融的成功率目前还不清楚。甲亢可能促进左心房致心律失常基质的形成,因此胺碘酮相关的甲亢可能导致房颤的复发率增高,据此Mikhaylov EN等近来在JCE上发表了一篇临床研究。
该研究的对象为自2007年至2010年于作者中心行导管消融的房颤患者,其中20例既往存在胺碘酮相关甲亢,对照组选择胺碘酮治疗无效的且甲状腺功能正常的患者40例。所有患者均进行了环肺静脉消融术,平均随访12个月。结果显示:既往甲亢的患者中有6例没有房性心律失常发作,占30%,而对照组为62.5%。7例患者发作房性心动过速,占35%,而对照组为2.5%;10例患者发作心房颤动,占50%,而对照组为7.5%。进行再次消融时发现与消融线无关的心动过速有5例,占25%,而对照组没有;再次消融后房颤的无复发率为60%,对照组为70%,两组无明显统计学差异。胺碘酮相关甲亢是房性心律失常发生的独立预测因子。
通过该项研究可得出以下结论:存在胺碘酮相关甲亢的房颤患者单纯环肺静脉消融术后复发率较高,而经过再次消融后,房性心律失常的复发率与无甲亢的患者相当。
与房颤相关的拓展阅读:
- Neurology:植入性循环心电检测仪明显提高隐源性卒中的房颤检出率
- Neurology:新诊断房颤与晨起卒中和TIA独立相关
- Nat Rev Cardiol:瑜伽有助于改善房颤患者的房颤负荷
- CAE:房颤患者消融围手术期服用达比加群的安全性
- ACC 2013:房颤患者首次应用地高辛死亡率升高
- Ann Intern Med:房颤增痴呆风险再添新证 更多信息请点击:有关房颤更多威廉亚洲官网
Catheter Ablation of Paroxysmal Atrial Fibrillation in Patients with Previous Amiodarone-Induced Hyperthyroidism: A Case-Control Study.
INTRODUCTION
Many patients with atrial fibrillation (AF) receive amiodarone. Amiodarone-induced hyperthyroidism (AIH) may develop as a complication. We hypothesized that pulmonary vein (PV) isolation in patients with paroxysmal AF and history of AIH may yield a lower success rate.
METHODS AND RESULTS
Among 704 patients who underwent AF ablation in our center between 2007 and 2010, we identified 20 patients (mean age 58.3 ± 5.0 years; 11 males) with paroxysmal AF and overt AIH in the past. The control group consisted of 40 patients with amiodarone-refractory AF and no thyroid dysfunction. All patients underwent circumferential PV isolation. During redo procedures all tachycardias were targeted for ablation. During a 12-month follow-up, in the AIH group 6 (30%) patients were arrhythmia free after a single procedure, in comparison to 25 (62.5%) controls (P = 0.01). Atrial tachycardia (AT) was registered in 7 (35%) AIH patients and in 1 (2.5%) control patient (P = 0.001). AF recurred in 10 (50%) AIH versus 15 (37.5%) control patients (P = 0.2). Redo ablation was performed in 7 (35%) AIH patients and in 3 (7.5%) non-AIH patients (P = 0.01). During a redo procedure a PV-unrelated tachycardia was diagnosed in 5 (25%) AIH patients (vs 0 in the controls, P = 0.003). After the last performed ablation, 12 (60%) AIH patients and 28 (70%) controls had no recurrence, P = 0.56. AIH was an independent predictor of ATs.
CONCLUSION
PV isolation alone has a lower efficacy for preventing recurrence in paroxysmal AF in AIH patients. After repeat ablations, overall freedom from tachyarrhythmias is similar to patients with no history of thyroid dysfunction.
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
#JCE#
55
#复发率#
47
#胺碘酮#
37
#导管消融#
58
#消融#
61
#房颤患者#
44